Hatch softens stance on Biologics, wants TPP to pass
[ Daily News| September 08, 2016 | Inside US Trade] Senate Finance Committee Chairman Orrin Hatch (R-UT) this week said commitments from Trans-Pacific Partnership countries on his demand for 12 years of market exclusivity for biologic drugs would not have to be framed in a contract or a side agreement – but rather as a “methodology”…